Literature DB >> 3828954

Perfusion of colorectal hepatic metastases. Relative distribution of flow from the hepatic artery and portal vein.

J A Ridge, J R Bading, A S Gelbard, R S Benua, J M Daly.   

Abstract

The importance of portal circulation in the delivery of drugs and nutrients to colorectal hepatic metastases is controversial. Using 13N (nitrogen 13) amino acids and ammonia with dynamic gamma camera imaging, we demonstrate, for the first time in human beings, a quantitative advantage of hepatic artery compared with portal vein infusion. Eleven patients were studied by hepatic artery injection, five patients were studied by portal vein injection, and two patients had injections through both routes. Data collected from the liver for 10 minutes after rapid bolus injection of 13N L-glutamate, L-glutamine, or ammonia were compared with 99mTc (technetium) macroaggregated albumin (MAA) images produced after injection through the hepatic artery or portal vein at the same session. Tumor regions defined from 99mTc sulfur colloid scans were compared with nearby liver areas of similar thickness. For the 13N compounds, the area-normalized count rate at first pass maximum (Qmax) and the tissue extraction efficiency were computed. The tumor/liver Qmax ratios for MAA and 13N compounds were highly correlated. Both tumor and liver extracted more than 70% of the nitrogenous compounds. The tumor/liver Qmax ratios reflect the relative delivery of injected tracer per unit volume of tissue. After hepatic artery injection the Qmax ratio was 1.03 +/- 0.33 (mean +/- SD), significantly exceeding the Qmax ratio of 0.50 +/- 0.34 after portal vein injection (P less than 0.003). Therefore, more than twice as much of a nutrient substrate is delivered per volume of tumor relative to liver by the hepatic artery as by the portal vein; the high extraction efficiency demonstrates that the hepatic artery flow is nutritive; and the delivery of substance in solution (such as nutrients or drugs) to tumor and liver tissue correlates with the distribution of colloids such as macroaggregated albumin after hepatic arterial and portal venous injection.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3828954     DOI: 10.1002/1097-0142(19870501)59:9<1547::aid-cncr2820590903>3.0.co;2-6

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  25 in total

Review 1.  Potential use of Doppler perfusion index in detection of occult liver metastases from colorectal cancer.

Authors:  Mario Kopljar; Leonardo Patrlj; Zeljko Bušić; Marijan Kolovrat; Mislav Rakić; Robert Kliček; Marcel Zidak; Igor Stipančić
Journal:  Hepatobiliary Surg Nutr       Date:  2014-10       Impact factor: 7.293

Review 2.  Hepatic arterial chemotherapy for primary and metastatic liver cancers.

Authors:  W Ensminger
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

3.  Hepatic artery chemotherapy in the management of colorectal metastases.

Authors:  Stacy L Stratmann
Journal:  Proc (Bayl Univ Med Cent)       Date:  2002-10

4.  Intra-arterial hepatic chemotherapy for liver malignancy.

Authors:  S T Malik; P F Wrigley
Journal:  BMJ       Date:  1988-08-13

5.  The use of perfusion CT for the evaluation of therapy combining AZD2171 with gefitinib in cancer patients.

Authors:  Martijn R Meijerink; Hester van Cruijsen; Klaas Hoekman; Matthijs Kater; Cors van Schaik; Jan Hein T M van Waesberghe; Giuseppe Giaccone; Radu A Manoliu
Journal:  Eur Radiol       Date:  2006-10-27       Impact factor: 5.315

Review 6.  Intraportal chemotherapy for colorectal hepatic metastases.

Authors:  U T Laffer; U Metzger
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

7.  Early effect of hepatic artery TNF-alpha infusion on systemic hemodynamics and inflammation: a dose-response study in pigs.

Authors:  Thilo Schäfer; Jens Sperling; Otto Kollmar; Sven Richter; Martin K Schilling; Michael D Menger; Werner Lindemann
Journal:  Int J Colorectal Dis       Date:  2009-11-04       Impact factor: 2.571

8.  Treatment of hepatic-metastatic colorectal cancer with a chemotherapeutic emulsion: interim results of a phase I trial.

Authors:  J T Rubin; M T Lotze; D Rosenfelder; A Brumfield; R Howells; R Schwartz; S Sylvestri; J Sammon; K Bron; P Orens
Journal:  Ann Surg Oncol       Date:  1995-07       Impact factor: 5.344

9.  Radiomics Response Signature for Identification of Metastatic Colorectal Cancer Sensitive to Therapies Targeting EGFR Pathway.

Authors:  Laurent Dercle; Lin Lu; Lawrence H Schwartz; Min Qian; Sabine Tejpar; Peter Eggleton; Binsheng Zhao; Hubert Piessevaux
Journal:  J Natl Cancer Inst       Date:  2020-09-01       Impact factor: 13.506

10.  Development of arterial blood supply in experimental liver metastases.

Authors:  Katalin Dezso; Edina Bugyik; Veronika Papp; Viktória László; Balázs Döme; József Tóvári; József Tímár; Péter Nagy; Sándor Paku
Journal:  Am J Pathol       Date:  2009-07-02       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.